ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,484Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 252

$638K Total Retail Price of All Prescriptions

Rank: 65 out of 252

632 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 632 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 632 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 9,097 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
OMEPRAZOLE 435 359 1 6
SIMVASTATIN 425 401 2 2
HYDROCODONE-ACETAMINOPHEN 402 290 S3 3 5
LEVOTHYROXINE SODIUM 378 364 4 1
AMLODIPINE BESYLATE 377 366 5 4
ZOLPIDEM TARTRATE 213 198 6 21
METFORMIN HCL 197 195 7 9
PRAVASTATIN SODIUM 188 177 8 12
POTASSIUM CHLORIDE 186 177 9 8
LOSARTAN-HYDROCHLOROTHIAZIDE 167 150 10 49
GABAPENTIN 163 136 11 11
SERTRALINE HCL 159 132 12 27
WARFARIN SODIUM 148 142 13 14
LISINOPRIL 142 140 14 3
TAMSULOSIN HCL 139 132 15 26
FENOFIBRATE 138 132 16 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 135 103 17 25
LOSARTAN POTASSIUM 125 120 18 24
CARVEDILOL 122 122 19 22
METOPROLOL TARTRATE 117 103 20 10
TRIAMTERENE-HCTZ 115 103 21 33
FUROSEMIDE 113 105 22 7
METOPROLOL SUCCINATE 108 102 23 19
ALENDRONATE SODIUM 108 108 23 32
HYDROCHLOROTHIAZIDE 101 97 25 13
KLOR-CON M20 97 89 26 69
CARISOPRODOL 94 32 R 27 70
CLOPIDOGREL 94 78 27 29
GLYBURIDE-METFORMIN HCL 88 84 R 29 82
ATENOLOL 87 76 30 18
ATORVASTATIN CALCIUM 81 65 31 16
DIGOXIN 75 74 32 44
LYRICA 75 57 32 66
CITALOPRAM HBR 73 71 34 15
QUINAPRIL HCL 73 65 34 120
NEXIUM 71 53 36 23
ALLOPURINOL 71 63 36 30
FINASTERIDE 68 68 38 115
SUCRALFATE 68 33 38 125
FLUTICASONE PROPIONATE 68 56 38 36
MELOXICAM 67 67 41 20
GLYBURIDE 66 62 R 42 78
GLIMEPIRIDE 65 65 43 40
TRAMADOL HCL 62 52 44 17
AMITRIPTYLINE HCL 61 28 R 45 46
AMLODIPINE BESYLATE-BENAZEPRIL 61 54 45 60
CRESTOR 60 56 47 34
NAPROXEN 60 50 47 96
DONEPEZIL HCL 58 58 49 28
CYMBALTA 56 20 50 45
SPIRONOLACTONE 55 51 51 53
NAMENDA 54 54 52 41
CLONIDINE HCL 54 48 52 35
TRAZODONE HCL 53 47 54 31
DICLOFENAC SODIUM 52 52 55 128
SYNTHROID 50 43 56 47
PROMETHAZINE HCL 50 18 R 56 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.